Literature DB >> 2120065

Restoration of H-2b expression and processing of endogenous antigens in the MHC class I pathway by fusion of a lymphoma mutant to L cells of the H-2k haplotype.

C Ohlén1, J Bastin, H G Ljunggren, S Imreh, G Klein, A R Townsend, K Kärre.   

Abstract

The RMA-S lymphoma mutant cannot process and present antigens to H-2-restricted cytotoxic T lymphocytes. It synthesizes major histocompatibility complex class I heavy (H-2KbDb) and light beta 2-microglobulin (beta 2mb) chains of normal size and charge, but only a fraction of these assemble and reach the cell surface. As a first step investigating the genetic defect of this line, we have fused it to a L cell fibroblast line (H-2KkDk/beta 2ma). The fusion restored H-2Kb, Db and beta 2mb expression as well as the ability to process and present internally derived (minor histocompatibility and influenza virus nucleoprotein) antigens in RMA-S. This shows that the mutation(s) responsible for the phenotype of RMA-S is (are) not located within the MHC class I heavy and light chain genes. Other cellular factors, derived from the L cell fusion partner, can control antigen processing and transport of MHC class I molecules. These findings are discussed in relation to the observation that assembly and transport of MHC class I molecules can be induced in the mutant by H-2b-restricted peptides. The recessive nature of the defect and its independence of MHC class I genes in the mutant has important implications for future transfection studies, of this and similar mutants, aiming at establishing cells containing non-assembled MHC class I molecules of different alleles and identifying the gene(s) controlling processing of endogenous antigens.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2120065     DOI: 10.1002/eji.1830200837

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  12 in total

1.  The selective proteasome inhibitors lactacystin and epoxomicin can be used to either up- or down-regulate antigen presentation at nontoxic doses.

Authors:  K Schwarz; R de Giuli; G Schmidtke; S Kostka; M van den Broek; K B Kim; C M Crews; R Kraft; M Groettrup
Journal:  J Immunol       Date:  2000-06-15       Impact factor: 5.422

2.  High-resolution one-dimensional isoelectric focusing of mouse MHC class I antigens. Identification of natural and experimentally induced class I antigens.

Authors:  H G Ljunggren; M Oudshoorn-Snoek; M G Masucci; H L Ploegh
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

3.  Recognition of vaccinia virus-encoded major histocompatibility complex class I antigens by virus immune cytotoxic T cells is independent of the polymorphism of the peptide transporters.

Authors:  M Lobigs; A Müllbacher
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

4.  Protective immunity does not correlate with the hierarchy of virus-specific cytotoxic T cell responses to naturally processed peptides.

Authors:  A Gallimore; T Dumrese; H Hengartner; R M Zinkernagel; H G Rammensee
Journal:  J Exp Med       Date:  1998-05-18       Impact factor: 14.307

5.  T cell receptor engagement by peptide-MHC ligands induces a conformational change in the CD3 complex of thymocytes.

Authors:  Diana Gil; Adam G Schrum; Balbino Alarcón; Ed Palmer
Journal:  J Exp Med       Date:  2005-02-21       Impact factor: 14.307

6.  Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class I-peptide complexes.

Authors:  A Gallimore; A Glithero; A Godkin; A C Tissot; A Plückthun; T Elliott; H Hengartner; R Zinkernagel
Journal:  J Exp Med       Date:  1998-05-04       Impact factor: 14.307

7.  RMA/S cells present endogenously synthesized cytosolic proteins to class I-restricted cytotoxic T lymphocytes.

Authors:  F Esquivel; J Yewdell; J Bennink
Journal:  J Exp Med       Date:  1992-01-01       Impact factor: 14.307

8.  Peptide-induced stabilization and intracellular localization of empty HLA class I complexes.

Authors:  E J Baas; H M van Santen; M J Kleijmeer; H J Geuze; P J Peters; H L Ploegh
Journal:  J Exp Med       Date:  1992-07-01       Impact factor: 14.307

9.  Recognition of carbohydrate by major histocompatibility complex class I-restricted, glycopeptide-specific cytotoxic T lymphocytes.

Authors:  J S Haurum; G Arsequell; A C Lellouch; S Y Wong; R A Dwek; A J McMichael; T Elliott
Journal:  J Exp Med       Date:  1994-08-01       Impact factor: 14.307

10.  An endogenous antigenic peptide bypasses the class I antigen presentation defect in RMA-S.

Authors:  N A Hosken; M J Bevan
Journal:  J Exp Med       Date:  1992-03-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.